Global Blood Therapeutics (NasdaqGS: GBT) shares climbed Thursday, lifting biotechnology sector-related exchange traded funds, on speculation of takeover bids for the small drug developer. On Thursday, the Virtus LifeSci Biotech Products ETF (BBP) rose 7.2%, the SPDR S&P Biotech ETF (XBI) increased 5.2%, and the ALPS Medical Breakthroughs ETF (SBIO) was up 5.1%. Meanwhile, Global [...] The post Biotech ETFs Advance on Speculation of a Takeover Bid for Global Blood Therapeutics appeared first on ETF Trends .